Search Results - Yong‐Oon Ahn

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Lineage relationships of human interleukin-22–producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells

    Lineage relationships of human interleukin-22–producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells by Yong‐Oon Ahn, Bruce R. Blazar, Jeffrey S. Miller, Michael R. Verneris

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Development of IL-22–producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue

    Development of IL-22–producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue by Qin Tang, Yong‐Oon Ahn, Peter J. Southern, Bruce R. Blazar, Jeffrey S. Miller, Michael R. Verneris

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    The Effects of 1,25-Dihydroxyvitamin D3 on In Vitro Human NK Cell Development from Hematopoietic Stem Cells

    The Effects of 1,25-Dihydroxyvitamin D3 on In Vitro Human NK Cell Development from Hematopoietic Stem Cells by Matthew Weeres, Kim Robien, Yong‐Oon Ahn, Marie‐Luise Neulen, Rachel J. Bergerson, Jeffrey S. Miller, Michael R. Verneris

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib

    Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib by Seulki Kim, Tae Min Kim, Dong‐Wan Kim, Soyeon Kim, Miso Kim, Yong‐Oon Ahn, Bhumsuk Keam, Dae Seog Heo

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma

    Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma by Seong-Ho Kang, Bhumsuk Keam, Yong‐Oon Ahn, Ha-Ram Park, Miso Kim, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Mechanisms of Acquired Resistance to AZD9291

    Mechanisms of Acquired Resistance to AZD9291 by Tae Min Kim, Ahnah Song, Dong‐Wan Kim, Soyeon Kim, Yong‐Oon Ahn, Bhumsuk Keam, Yoon Kyung Jeon, Se‐Hoon Lee, Doo Hyun Chung, Dae Seog Heo

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Targeting Rat Brainstem Glioma Using Human Neural Stem Cells and Human Mesenchymal Stem Cells

    Targeting Rat Brainstem Glioma Using Human Neural Stem Cells and Human Mesenchymal Stem Cells by Do‐Hun Lee, Yong‐Oon Ahn, Seung Up Kim, Kyu‐Chang Wang, Byung-Kyu Cho, Ji Hoon Phi, In Ho Park, Peter McL. Black, Rona S. Carroll, Joonyub Lee, Seung-Ki Kim

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type

    Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type by Sung Hoon Sim, Soyeon Kim, Tae Min Kim, Yoon Kyung Jeon, Soo Jeong Nam, Yong‐Oon Ahn, Bhumsuk Keam, Hyun Ho Park, Dong‐Wan Kim, Chul Woo Kim, Dae Seog Heo

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer

    Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer by Ji‐Won Kim, Youngil Koh, Dong‐Wan Kim, Yong‐Oon Ahn, Tae Min Kim, Sae‐Won Han, Do‐Youn Oh, Se‐Hoon Lee, Seock‐Ah Im, Tae‐You Kim, Dae Seog Heo, Yung‐Jue Bang

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors

    Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors by Yaewon Yang, Okjae Lim, Tae Min Kim, Yong‐Oon Ahn, Hana Choi, Hyejin Chung, Bokyung Min, Jung Hyun Her, Sung Yoo Cho, Bhumsuk Keam, Se‐Hoon Lee, Dong‐Wan Kim, Yu Kyeong Hwang, Dae Seog Heo

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma

    Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma by Chan-Young Ock, Sehui Kim, Bhumsuk Keam, Soyeon Kim, Yong‐Oon Ahn, Eun‐Jae Chung, Jin-Ho Kim, Tae Min Kim, Seong Keun Kwon, Yoon Kyung Jeon, Kyeong Chun Jung, Dong‐Wan Kim, Hong-Gyun Wu, Myung‐Whun Sung, Dae Seog Heo

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: